Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Matthew McGrew Biography and Net Worth

CFO of Danaher

Matt was appointed as Danaher's EVP & CFO in January 2019. Prior to that, he served as Group CFO for several of Danaher's Platforms including Diagnostics, Dental, Life Sciences and PID. Matt joined Danaher in April 2004 and has held positions of increasing responsibility within Internal Audit, M&A and served as Vice President of Investor Relations. Prior to joining Danaher, Matt was a Director in the Transactions Services Group at KPMG in Chicago, where he worked since 1994.

Matt holds a Bachelor of Science degree in Accounting from DePaul University.

What is Matthew McGrew's net worth?: The estimated net worth of Matthew McGrew is at least $6.94 million as of August 1st, 2024. Mr. McGrew owns 29,407 shares of Danaher stock worth more than $6,935,053 as of November 22nd. This net worth evaluation does not reflect any other assets that Mr. McGrew may own. Additionally, Mr. McGrew receives a salary of $2,560,000.00 as CFO at Danaher. Learn More about Matthew McGrew's net worth.
How old is Matthew McGrew?: Mr. McGrew is currently 52 years old. There are 7 older executives and no younger executives at Danaher. The oldest executive at Danaher is Mr. Steven M. Rales, Co-Founder & Chairman, who is 73 years old. Learn More on Matthew McGrew's age.
What is Matthew McGrew's salary?: As the CFO of Danaher Co., Mr. McGrew earns $2,560,000.00 per year. There are 2 executives that earn more than Mr. McGrew. The highest earning executive at Danaher is Mr. Rainer M. Blair, President, CEO & Director, who commands a salary of $5,330,000.00 per year. Learn More on Matthew McGrew's salary.
How do I contact Matthew McGrew?: The corporate mailing address for Mr. McGrew and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Matthew McGrew's contact information.
Has Matthew McGrew been buying or selling shares of Danaher?: Matthew McGrew has not been actively trading shares of Danaher in the last ninety days. Most recently, Matthew Mcgrew sold 16,172 shares of the business's stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $279.84, for a transaction totalling $4,525,572.48. Following the completion of the sale, the chief financial officer now directly owns 29,407 shares of the company's stock, valued at $8,229,254.88. Learn More on Matthew McGrew's trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (President, CEO & Director), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 16 times. They sold a total of 221,399 shares worth more than $56,844,951.46. The most recent insider tranaction occured on August, 26th when SVP Georgeann Couchara sold 952 shares worth more than $255,488.24. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 8/26/2024.

Matthew McGrew Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2024	Sell	16,172	$279.84	$4,525,572.48	29,407
5/10/2024	Sell	46,377	$253.05	$11,735,699.85	29,407
11/11/2022	Sell	18,935	$274.72	$5,201,823.20	29,634
11/26/2021	Sell	2,589	$325.50	$842,719.50
7/28/2021	Sell	12,310	$293.40	$3,611,754.00	14,874
7/29/2020	Sell	7,457	$203.42	$1,516,902.94	12,387
2/3/2020	Sell	11,304	$161.98	$1,831,021.92	21,320
4/29/2019	Sell	22,738	$130.89	$2,976,176.82	27,534

Matthew McGrew Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Today's Range

Now: $235.83

$234.73

$236.84

50 Day Range

MA: $258.15

$229.50

$278.02

2 Week Range

Now: $235.83

$215.68

$281.70

Volume

2,330,134 shs

Average Volume

2,761,292 shs

Market Capitalization

$170.33 billion

P/E Ratio

45.01

Dividend Yield

0.47%

Beta

0.85

Let’s be blunt

From DTI | Ad

Check out the $100 Challenge now

Matthew McGrew Biography and Net Worth

What is Matthew McGrew's net worth?

How old is Matthew McGrew?

What is Matthew McGrew's salary?

How do I contact Matthew McGrew?

Has Matthew McGrew been buying or selling shares of Danaher?

Who are Danaher's active insiders?

Are insiders buying or selling shares of Danaher?